Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.

BACKGROUND: A recent randomized trial compared a policy of no prophylaxis with a policy of prophylactic platelet (PLT) transfusions at counts of fewer than 10 × 10(9) /L in patients with hematologic malignancies. The results suggested the effectiveness of prophylactic PLT transfusions may vary accor...

Bibliografske podrobnosti
Main Authors:	Stanworth, S, Estcourt, L, Llewelyn, C, Murphy, M, Wood, E
Format:	Journal article
Jezik:	English
Izdano:	2014

Podobne knjige/članki

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
od: Stanworth, S, et al.
Izdano: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
od: Campbell, H, et al.
Izdano: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
od: Campbell, H, et al.
Izdano: (2014)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
od: Stanworth, S, et al.
Izdano: (2015)

Prophylactic platelet transfusions
od: Estcourt, L, et al.
Izdano: (2010)

Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
od: Simon J. Stanworth, et al.
Izdano: (2015-06-01)

Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
od: Stanworth, S, et al.
Izdano: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Estcourt, L, et al.
Izdano: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
od: Estcourt, L, et al.
Izdano: (2012)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
od: Estcourt, L, et al.
Izdano: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
od: Estcourt, L, et al.
Izdano: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
od: Estcourt, L, et al.
Izdano: (2013)

Platelet transfusions for patients with haematological malignancies: who needs them?
od: Estcourt, L, et al.
Izdano: (2011)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
od: Estcourt, L, et al.
Izdano: (2014)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
od: Estcourt, L
Izdano: (2016)

Alternatives to prophylactic platelet transfusions
od: Estcourt, L
Izdano: (2016)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
od: Desborough, M, et al.
Izdano: (2016)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Estcourt, L, et al.
Izdano: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, et al.
Izdano: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
od: Estcourt, L, et al.
Izdano: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, et al.
Izdano: (2014)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
od: Estcourt, L, et al.
Izdano: (2015)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
od: Crighton, GL, et al.
Izdano: (2015)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
od: Estcourt, L, et al.
Izdano: (2017)

Observational study of alternative platelet parameters to predict bleeding risk in patients with hematological malignancies (ATHENA study)
od: Estcourt, L, et al.
Izdano: (2013)

A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
od: Stanworth, S, et al.
Izdano: (2013)

An update on indications for platelet transfusion
od: Wood, E, et al.
Izdano: (2016)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
od: Crighton, GL, et al.
Izdano: (2021)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
od: Stanworth, S, et al.
Izdano: (2004)

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
od: Stanworth, S, et al.
Izdano: (2004)

Prophylactic platelet transfusions.
od: Pietersz, R, et al.
Izdano: (2012)

Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review
od: Desborough, M, et al.
Izdano: (2016)

A UK national survey of prophylactic platelet transfusion thresholds in non-bleeding, critically ill adults
od: Shah, A, et al.
Izdano: (2020)

Platelet transfusions in patients with hypoproliferative thrombocytopenia: conclusions from clinical trials and current controversies
od: Crighton, G, et al.
Izdano: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
od: Estcourt, L, et al.
Izdano: (2014)

Alternatives to allogeneic platelet transfusion
od: Desborough, M, et al.
Izdano: (2016)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, et al.
Izdano: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
od: Estcourt, L, et al.
Izdano: (2018)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review
od: Desborough, M, et al.
Izdano: (2016)

Analysis of Current Patterns of Utilisation of Platelet Transfusion Components in Hematology Patients
od: Estcourt, L, et al.
Izdano: (2011)